SenesTech logo
SNESSenesTech
Trade SNES now
SenesTech primary media

About SenesTech

SenesTech (NASDAQ:SNES) specializes in developing technology for managing animal populations through fertility control. Focused primarily on reducing populations of invasive or prolific species like rats in urban and agricultural settings, their flagship product, ContraPest, targets the reproductive capabilities of rats, aiming to curb their numbers in a humane and environmentally friendly way. The company's innovative approach seeks not only to mitigate issues related to overpopulation of specific animal species but also to contribute to reducing the spread of diseases and agricultural damage associated with these populations. SenesTech's objectives revolve around expanding the adoption of their solutions across various markets while continuing to innovate in the field of fertility control technology.

What is SNES known for?

Snapshot

Public US
Ownership
2004
Year founded
29
Employees
Flagstaff, United States
Head office
1 of 5
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Flagstaff, US

Produtos e/ou serviços de SenesTech

  • ContraPest, a revolutionary fertility control product targeting rat populations effectively reduces reproduction.
  • Field studies service offering comprehensive evaluation of rodent infestations to tailor control strategies.
  • Application training for optimal use of their fertility control products, enhancing customer effectiveness.
  • Educational workshops for communities and businesses to understand and implement integrated pest management strategies.
  • Partnership programs with municipalities for urban rodent management, leveraging ContraPest in sustainable pest control solutions.
  • Technical support for customers to ensure successful implementation and maintenance of fertility control measures.

equipe executiva do SenesTech

  • Dr. Jamie Bechtel J.D., Ph.D.Interim Executive Chair
  • Mr. Joel L. FruendtCEO, President & Director
  • Mr. Thomas C. Chesterman M.B.A.Executive VP, CFO, Treasurer & Secretary
  • Mr. Michael EdellInterim Chief Operating Officer
  • Mr. Bryan Di MennaVice President of Sales
  • Robert BlumInvestor Relations

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.